In vitro and in vivo comparative study of a novel 68Ga-labeled PSMA-targeted inhibitor and 68Ga-PSMA-11
Abstract 68Ga-radiolabeled small molecules that specifically target prostate-specific membrane antigen (PSMA) have been extensively investigated, and some of these tracers have been used in the diagnosis of prostate cancer via 68Ga-positron emission tomography (68Ga-PET). Nevertheless, current 68Ga-...
Guardado en:
Autores principales: | Huanyu Chen, Ping Cai, Yue Feng, Zhanliang Sun, Yinwen Wang, Yue Chen, Wei Zhang, Nan Liu, Zhijun Zhou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d8390b3ca8f8484c8850c936c95a4d06 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biodistribution and internal radiation dosimetry of a companion diagnostic radiopharmaceutical, [68Ga]PSMA-11, in subcutaneous prostate cancer xenograft model mice
por: Su Bin Kim, et al.
Publicado: (2021) -
Accuracy of standard clinical 3T prostate MRI for pelvic lymph node staging: Comparison to 68 Ga-PSMA PET-CT
por: Sebastian Meißner, et al.
Publicado: (2019) -
68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors
por: Heying Duan, et al.
Publicado: (2022) -
Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of <sup>68</sup>Ga-PSMA and <sup>68</sup>Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients
por: Paola Mapelli, et al.
Publicado: (2021) -
Clinical Significance of Diffusely Increased Uptake of 68Ga-FAPI in Thyroid Gland
por: Huipan Liu, et al.
Publicado: (2021)